Literature DB >> 22406637

What we have learned about pancreatic cancer from mouse models.

Pedro A Pérez-Mancera1, Carmen Guerra, Mariano Barbacid, David A Tuveson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22406637     DOI： 10.1053/j.gastro.2012.03.002

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  88 in total

Review 1.  The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure.

Authors:  Gwen A Lomberk; Raul Urrutia
Journal:  Surg Clin North Am       Date:  2015-07-23       Impact factor: 2.741

2.  HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.

Authors:  Ling Li; Wenhua Tang; Xiaoqing Wu; David Karnak; Xiaojie Meng; Rachel Thompson; Xinbao Hao; Yongmin Li; Xiaotan T Qiao; Jiayuh Lin; James Fuchs; Diane M Simeone; Zhi-Nan Chen; Theodore S Lawrence; Liang Xu
Journal:  Clin Cancer Res       Date:  2013-10-16       Impact factor: 12.531

Review 3.  Pathogenesis of pancreatic cancer: lessons from animal models.

Authors:  L Charles Murtaugh
Journal:  Toxicol Pathol       Date:  2013-10-31       Impact factor: 1.902

Review 4.  Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation.

Authors:  Stacey J Coleman; Jennifer Watt; Prabhu Arumugam; Leonardo Solaini; Elisabeta Carapuca; Mohammed Ghallab; Richard P Grose; Hemant M Kocher
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

5.  RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.

Authors:  Martin C Whittle; Kamel Izeradjene; P Geetha Rani; Libing Feng; Markus A Carlson; Kathleen E DelGiorno; Laura D Wood; Michael Goggins; Ralph H Hruban; Amy E Chang; Philamer Calses; Shelley M Thorsen; Sunil R Hingorani
Journal:  Cell       Date:  2015-05-21       Impact factor: 41.582

6.  Direct reprogramming by oncogenic Ras and Myc.

Authors:  Irene Ischenko; Jizu Zhi; Ute M Moll; Alice Nemajerova; Oleksi Petrenko
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

7.  Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.

Authors:  Neus Martínez-Bosch; Maite G Fernández-Barrena; Mireia Moreno; Elena Ortiz-Zapater; Jessica Munné-Collado; Mar Iglesias; Sabine André; Hans-Joachim Gabius; Rosa F Hwang; Françoise Poirier; Carolina Navas; Carmen Guerra; Martin E Fernández-Zapico; Pilar Navarro
Journal:  Cancer Res       Date:  2014-05-08       Impact factor: 12.701

Review 8.  Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.

Authors:  Amedeo Amedei; Elena Niccolai; Domenico Prisco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.

Authors:  Weiying Zhang; Nivedita Nandakumar; Yuhao Shi; Mark Manzano; Alias Smith; Garrett Graham; Swati Gupta; Eveline E Vietsch; Sean Z Laughlin; Mandheer Wadhwa; Mahandranauth Chetram; Mrinmayi Joshi; Fen Wang; Bhaskar Kallakury; Jeffrey Toretsky; Anton Wellstein; Chunling Yi
Journal:  Sci Signal       Date:  2014-05-06       Impact factor: 8.192

Review 10.  Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Authors:  Lauri Eklund; Maija Bry; Kari Alitalo
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.